Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $113.89 million. The enterprise value is -$84.13 million.
| Market Cap | 113.89M |
| Enterprise Value | -84.13M |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 120.76 million shares outstanding. The number of shares has increased by 43.81% in one year.
| Current Share Class | 120.76M |
| Shares Outstanding | 120.76M |
| Shares Change (YoY) | +43.81% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.61% |
| Owned by Institutions (%) | 49.63% |
| Float | 81.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 517.67 |
| Forward PS | 1,015.40 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.18, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.18 |
| Quick Ratio | 5.09 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -331.72 |
Financial Efficiency
Return on equity (ROE) is -45.86% and return on invested capital (ROIC) is -30.27%.
| Return on Equity (ROE) | -45.86% |
| Return on Assets (ROA) | -24.92% |
| Return on Invested Capital (ROIC) | -30.27% |
| Return on Capital Employed (ROCE) | -40.39% |
| Weighted Average Cost of Capital (WACC) | 15.01% |
| Revenue Per Employee | $1,325 |
| Profits Per Employee | -$740,404 |
| Employee Count | 166 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -793,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.51% in the last 52 weeks. The beta is 1.99, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.99 |
| 52-Week Price Change | -55.51% |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | 3.45 |
| Relative Strength Index (RSI) | 29.69 |
| Average Volume (20 Days) | 4,404,006 |
Short Selling Information
The latest short interest is 8.97 million, so 7.43% of the outstanding shares have been sold short.
| Short Interest | 8.97M |
| Short Previous Month | 16.57M |
| Short % of Shares Out | 7.43% |
| Short % of Float | 11.03% |
| Short Ratio (days to cover) | 3.32 |
Income Statement
In the last 12 months, CATX had revenue of $220,000 and -$122.91 million in losses. Loss per share was -$1.17.
| Revenue | 220,000 |
| Gross Profit | -101.69M |
| Operating Income | -131.69M |
| Pretax Income | -123.90M |
| Net Income | -122.91M |
| EBITDA | -127.23M |
| EBIT | -131.69M |
| Loss Per Share | -$1.17 |
Balance Sheet
The company has $201.70 million in cash and $3.68 million in debt, with a net cash position of $198.02 million or $1.64 per share.
| Cash & Cash Equivalents | 201.70M |
| Total Debt | 3.68M |
| Net Cash | 198.02M |
| Net Cash Per Share | $1.64 |
| Equity (Book Value) | 294.68M |
| Book Value Per Share | 2.58 |
| Working Capital | 165.68M |
Cash Flow
In the last 12 months, operating cash flow was -$108.13 million and capital expenditures -$30.66 million, giving a free cash flow of -$138.79 million.
| Operating Cash Flow | -108.13M |
| Capital Expenditures | -30.66M |
| Depreciation & Amortization | 4.46M |
| Net Borrowing | -55,000 |
| Free Cash Flow | -138.79M |
| FCF Per Share | -$1.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | -59,860.45% |
| Pretax Margin | -56,316.82% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -43.81% |
| Shareholder Yield | -43.81% |
| Earnings Yield | -124.25% |
| FCF Yield | -121.87% |
Analyst Forecast
The average price target for CATX is $9.71, which is 930.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.71 |
| Price Target Difference | 930.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | -34.51% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CATX has an Altman Z-Score of 0.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.76 |
| Piotroski F-Score | 2 |